FDA Inspection
VIRTUS PHARMACEUTICALS OPCO II LVIRTUS PHARMACEUTICALS OPCO II L – FDA Inspection, Jun 9, 2017
Record Details
This FDA Inspection record concerns VIRTUS PHARMACEUTICALS OPCO II L, with an inspection on June 9, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c1722ae1-bfce-4585-af48-dcc764833adb
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1031034
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of VIRTUS PHARMACEUTICALS OPCO II L
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 23, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for VIRTUS PHARMACEUTICALS OPCO II L
- FDA Inspection 979139 - 2016-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.